Browsing by Author Hilpert, Felix

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2014Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mullerian Adenosarcoma of the Female Genital TractRussell, Peter; Covens, Alan; Friedlander, Michael; Glasspool, Rosalind; Hilpert, Felix; Kristensen, Gunnar; Kwon, Sanghoon; Selle, Frederic; Small, William; Witteveen, Els; Central Clinical School: PathologyGynecologic Cancer InterGroup (GCIG) Consensus Review for Mullerian Adenosarcoma of the Female Genital Tract, International Journal Of Gynecological Cancer, vol.24, 9 Supplement 3, 2014,pp S78-S82
2014Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian CancerKing, Madeleine; Lee, Chee Khoon; Stockler, Martin; Arranz, José Angel; de Gregorio, Nikolaus; et al, Various; Friedlander, Michael; Hilpert, Felix; Joly, Florence; Mirza, Mansoor Raza; Wenzel, Lari; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePatient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer, Journal of Clinical Oncology, vol.32, 13, 2014,pp 1309-1319
2017Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudyAsher, Rebecca; Davies, Lucy; Gebski, Val; Gibbs, Emma; King, Madeleine; Lee, Chee Khoon; Roncolato, Felicia; Stockler, Martin; Friedlander, Michael; Hilpert, Felix; Pujade-Lauraine, Eric; Wenzel, Lari; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreQuality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy, Annals of Oncology, vol.28, 8, 2017,pp 1849-1855
2017Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit StudyBuizen, L; King, Madeleine; O'Connell, Rachel; Roncolato, Felicia; Stockler, Martin; Aotani, Enriko; Avall-Lundqvist, Elisabeth; Berek, Jonathan; Berton-Rigaud, Dominique; Donnellan, Paul; Feeney, Amanda; Friedlander, M; Heitz, Florian; Hilpert, Felix; Joly, F; Lanceley, Anne; Okamoto, Aikou; Oza, Amit; Pignata, Sandro; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreReducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study, The Oncologist, vol.22, 9, 2017,pp 1117-1124